No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
189 |
4. Check minimum number of eventsNone |
189 |
5. Include endpointsNone |
189 |
6. Filter based on genotype QC (FinnGen only) |
159 |
Control definitions (FinnGen only)
- Control exclude
- AB1_OTHER_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Actinomycosis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Other bacterial diseases, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 159 | 84 | 75 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 56.32 | 52.62 | 60.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 168
- Matched controls
- 1680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A42.8
ICD-10 Finland
Other forms of actinomycosis
+∞
44.8
41
*
A42.9
ICD-10 Finland
Actinomycosis, unspecified
+∞
33.5
31
*
A42.0
ICD-10 Finland
Pulmonary actinomycosis
+∞
32.3
30
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
46.8
28.4
34
9
A42.2
ICD-10 Finland
Cervicofacial actinomycosis
+∞
22.4
21
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.4
15.4
28
51
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
14.8
14
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
13.7
13
*
A46
ICD-10 Finland
Erysipelas
6.3
13.3
24
43
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.9
13.2
33
80
A42.7
ICD-10 Finland
Actinomycotic sepsis
+∞
11.6
11
*
JN4BD
NOMESCO Finland
Extensive body CT
4.7
10.6
27
66
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
+∞
10.5
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
9.5
24
58
A42
ICD-10 Finland
Actinomycosis
+∞
8.4
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
8.3
56
256
TGC00
NOMESCO Finland
Bronchial lavation
12.6
8.2
14
12
R50.9
ICD-10 Finland
Fever, unspecified
3.4
8.1
33
113
11399
ICD-8 Finland
Actinomycosis
+∞
7.3
7
*
A42.1
ICD-10 Finland
Abdominal actinomycosis
+∞
7.3
7
*
N02AA05
ATC
oxycodone; systemic
2.9
7.3
40
163
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
7.1
38
152
M04AA01
ATC
allopurinol; systemic
3.4
7.0
28
94
K05.31
ICD-10 Finland
Periodontitis pronounced
3.3
6.7
27
91
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.5
6.6
25
81
A06AD11
ATC
lactulose; oral
3.0
6.5
32
122
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
6.4
76
444
J01FF01
ATC
clindamycin; systemic
2.4
6.3
53
266
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.3
83
507
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.2
6.3
13
17
R2110
NOMESCO Finland
Giving the first information
4.4
6.2
16
39
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
5.6
6.2
17
33
TLC02
NOMESCO Finland
Simple extraction of IUD
7.7
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
30
31
11.56
26.70
2.9
2.2
—
—
—
0
0
49
178
3.47
11.19
2.5
1.7
—
—
—
0
0
24
52
5.22
10.86
7.3
1.8
2.77
1.73
mmol/l
0.47
18
41
30
79
4.41
10.77
2.0
1.3
—
—
—
0
0
40
136
3.55
10.03
1.5
1.6
—
—
—
0
0
97
567
2.68
8.96
8.0
3.6
33.44
36.29
g/l
3.33
91
532
19
29
7.24
8.16
1.8
1.2
—
—
—
0
0
17
22
8.46
8.10
2.0
1.4
—
—
—
0
0
16
19
9.18
8.02
1.8
1.2
—
—
—
0
0
17
40
4.62
6.93
1.3
3.7
1.12
3.14
ratio
0.68
11
18
12
11
11.64
6.91
1.2
1.1
—
—
—
0
0
18
33
5.98
6.84
1.8
1.2
—
—
—
0
0
45
204
2.65
6.66
5.7
2.5
0.80
0.82
mmol/l
0.30
45
190
112
767
2.38
6.51
17.4
8.5
4.11
3.90
e9/l
0.51
100
669
15
23
7.05
6.50
1.5
1.5
—
—
—
0
0
34
135
2.90
6.45
1.6
1.7
—
—
—
0
0
11
12
9.71
5.88
2.0
1.4
—
—
—
0
0
10
9
11.72
5.87
2.2
1.3
—
—
—
0
0
10
9
11.72
5.87
2.2
1.3
—
—
—
0
0
10
9
11.72
5.87
1.5
1.0
—
—
—
0
0
10
9
11.72
5.87
2.2
1.3
—
—
—
0
0
97
646
2.19
5.75
12.8
5.9
1.22
1.22
mmol/l
0.19
85
562
14
24
6.26
5.67
1.4
1.2
—
—
—
0
0
134
1029
2.49
5.49
16.3
6.7
86.57
76.80
u/l
0.84
128
961
10
11
9.58
5.36
2.0
1.5
—
—
—
0
0
14
26
5.77
5.36
1.4
1.2
—
—
—
0
0
11
15
7.76
5.23
1.3
1.1
—
—
—
0
0
7
5
14.52
4.61
2.9
2.2
0.67
0.43
e9/l
—
7
5
11
19
6.11
4.52
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
28
4.94
4.47
1.7
1.7
0.25
0.28
iu/ml
—
8
13
15
38
4.23
4.43
1.3
1.1
—
—
—
0
0
9
12
7.85
4.41
1.1
1.0
—
—
—
0
0
64
404
1.94
4.02
4.6
3.3
952.36
1046.86
ng/l
0.19
56
337
68
439
1.92
3.99
3.9
3.1
47.15
29.36
u/l
0.84
68
411
26
115
2.49
3.96
3.0
1.8
441.92
383.77
nmol/l
0.46
26
107
10
20
5.24
3.75
1.9
1.2
—
—
—
0
0
15
51
3.13
3.68
1.5
2.0
40.87
43.35
u/l
0.17
15
43
74
504
1.84
3.59
5.5
3.6
31.24
52.10
ng/l
0.95
55
358
9
18
5.22
3.42
1.4
1.2
—
—
—
0
0
53
329
1.89
3.42
3.7
2.0
—
—
—
0
0
125
1020
1.88
3.17
6.7
4.0
18.59
10.81
mm/h
3.99
118
945
9
20
4.69
3.16
2.7
1.4
—
—
—
0
0
8
16
5.19
3.09
1.6
1.2
—
—
—
0
0
6
8
7.72
3.08
1.0
1.0
—
—
—
0
0
5
5
10.25
2.99
1.4
1.0
—
—
—
0
0
5
5
10.25
2.99
1.4
1.0
—
—
—
0
0
5
5
10.25
2.99
1.0
1.0
—
—
—
0
0
12
38
3.32
2.92
4.2
1.7
—
—
—
0
0
31
170
2.01
2.83
10.6
7.3
103.97
103.80
mmol/l
0.09
31
170
5
6
8.54
2.76
1.4
1.0
—
—
—
0
0
12
40
3.15
2.76
1.4
1.3
—
—
—
0
0
6
10
6.17
2.72
1.0
1.0
—
—
—
0
0
12
41
3.07
2.68
1.0
1.1
—
—
—
0
0
8
20
4.14
2.60
2.1
1.2
—
—
—
0
0
11
37
3.11
2.54
3.1
1.7
—
—
—
0
0
20
97
2.21
2.49
1.7
2.3
6.51
6.84
ug/l
0.03
14
85
5
8
6.40
2.39
1.8
1.0
—
—
—
0
0
64
459
1.64
2.38
6.5
2.8
2.34
2.36
mmol/l
0.67
57
423
21
107
2.10
2.33
7.5
8.4
1.11
1.29
mmol/l
0.42
21
107
8
23
3.60
2.30
1.3
1.7
—
—
—
0
0
8
23
3.60
2.30
1.8
1.2
—
—
—
0
0
7
18
4.01
2.27
1.4
1.5
—
—
—
0
0
33
199
1.82
2.27
1.5
1.5
—
—
—
0
0
49
333
1.67
2.23
3.7
2.5
323.46
338.98
umol/l
0.55
41
292
82
635
1.57
2.17
3.7
2.9
212.19
97.13
ug/l
2.07
72
590
5
10
5.11
2.08
1.0
1.0
—
—
—
0
0
44
296
1.66
2.07
1.7
1.7
1.53
1.14
mg/l
0.37
36
240
6
15
4.11
2.06
1.0
1.4
—
—
—
0
0
6
15
4.11
2.06
1.0
1.4
—
—
—
0
0
8
26
3.18
2.04
1.5
2.4
—
—
—
0
0
13
59
2.30
1.89
2.3
1.4
—
—
—
0
0
36
236
1.67
1.86
2.9
2.8
1.36
1.00
e6/l
0.21
20
119
41
279
1.62
1.83
4.4
2.5
2.46
2.44
mmol/l
0.39
34
255
7
23
3.13
1.82
6.4
2.0
10.06
8.21
pmol/l
—
7
23
13
62
2.19
1.70
1.4
1.2
—
—
—
0
0
52
381
1.53
1.69
4.0
2.9
0.17
0.35
e6/l
1.29
41
262
73
578
1.47
1.62
2.2
2.0
91.68
97.87
pmol/l
0.68
41
302
15
78
2.01
1.60
10.1
8.2
26.99
24.90
mmol/l
0.99
15
78
5
15
3.40
1.53
3.2
3.7
—
—
—
0
0
19
111
1.80
1.46
6.4
2.7
3.45
1.93
mmol/l
0.87
19
99
78
635
1.43
1.46
4.0
2.4
—
—
estimate
—
0
0
15
81
1.94
1.45
10.9
11.0
0.60
0.64
%
0.18
15
81
7
29
2.47
1.41
2.0
1.6
123.43
226.63
ug/l
—
7
29
144
1322
1.62
1.39
36.2
12.5
28.58
22.04
mg/l
1.51
126
1050
15
83
1.89
1.36
11.1
10.6
1.40
1.35
%
0.09
15
83
98
839
1.40
1.34
3.3
3.0
—
—
—
0
0
51
390
1.44
1.32
1.8
1.6
22.23
20.93
nmol/l
0.30
42
330
10
48
2.15
1.30
1.5
1.3
1.24
1.20
g/l
—
10
48
10
48
2.15
1.30
2.5
1.3
0.24
0.23
g/l
—
10
48
44
328
1.46
1.29
1.4
1.3
4.29
1.40
u/ml
0.39
13
91
118
1048
1.42
1.27
4.6
4.2
15.11
14.69
pmol/l
0.97
107
955
5
19
2.68
1.22
1.0
1.3
—
—
—
0
0
13
74
1.82
1.10
9.6
11.1
26.20
24.61
mmol/l
0.71
13
74
5
21
2.42
1.10
1.0
1.2
—
—
—
0
0
5
21
2.42
1.10
1.0
1.2
—
—
—
0
0
5
21
2.42
1.10
1.0
1.2
—
—
—
0
0
7
33
2.17
1.07
1.1
1.2
—
—
—
0
0
7
34
2.10
1.04
1.1
1.3
—
—
—
0
0
19
124
1.60
1.02
5.6
3.2
—
—
—
0
0
48
380
1.37
1.00
5.6
3.9
0.00
0.01
estimate
0.50
16
135
5
23
2.21
0.98
1.2
1.7
—
—
—
0
0
5
23
2.21
0.98
1.0
1.2
—
—
—
0
0
5
23
2.21
0.98
1.0
1.2
—
—
—
0
0
82
706
1.32
0.97
4.9
3.7
0.00
0.00
estimate
-0.00
18
146
29
212
1.44
0.95
3.1
3.0
1.69
2.48
e6/l
0.26
13
96
6
27
2.27
0.94
1.7
1.7
—
—
—
0
0
19
127
1.56
0.93
4.8
5.1
4.14
5.90
ug/l
0.45
14
102
15
96
1.62
0.88
4.7
2.1
59.86
71.30
ml/min/173m2
—
7
37
82
715
1.29
0.86
5.0
3.7
0.00
10.83
estimate
0.50
18
150
106
956
1.29
0.85
5.2
2.9
58.25
46.87
u/l
0.55
99
902
6
32
1.91
0.82
1.2
1.1
—
—
—
0
0
82
719
1.27
0.81
5.2
3.7
0.00
0.00
estimate
-0.00
15
143
11
66
1.71
0.81
7.2
2.8
24.76
24.79
mmol/l
0.00
11
66
6
33
1.85
0.80
1.2
1.1
—
9.76
—
0
5
90
800
1.27
0.78
7.2
4.4
6.69
6.47
mmol/l
0.53
90
751
32
254
1.32
0.66
1.4
1.4
29.88
8.29
u/ml
0.48
11
109
33
406
0.77
0.65
4.2
3.0
0.00
0.00
estimate
-0.00
14
116
11
71
1.59
0.64
2.4
2.1
—
—
—
0
0
130
1368
0.78
0.62
6.3
5.7
2.73
2.73
mmol/l
0.02
120
1265
5
30
1.69
0.62
1.2
1.3
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
32
259
1.29
0.58
1.4
1.9
443.79
447.50
pmol/l
0.03
24
218
6
35
1.74
0.58
1.7
1.1
618.17
472.11
mg/l
—
6
35
34
278
1.28
0.57
1.4
1.3
62.07
29.14
iu/ml
—
7
86
68
604
1.21
0.55
2.9
2.3
74.65
77.29
nmol/l
0.37
59
541
6
38
1.60
0.55
1.7
1.3
—
38.33
—
0
6
30
364
0.79
0.53
4.6
4.3
19.24
22.71
%
0.79
15
176
15
109
1.41
0.53
2.4
2.1
5.17
0.23
e6/l
0.46
15
102
12
85
1.44
0.48
2.5
2.2
—
—
—
0
0
136
1303
1.23
0.44
27.8
12.9
82.43
82.02
ml/min/173m2
0.07
125
1200
21
167
1.29
0.44
1.5
1.8
1.66
1.45
%
0.44
16
151
13
166
0.76
0.35
3.3
2.4
—
—
—
0
0
123
1278
0.86
0.33
7.4
5.9
39.63
38.77
mmol/mol
0.44
116
1196
130
1345
0.85
0.33
5.2
4.9
1.48
1.47
mmol/l
0.04
120
1241
40
447
0.86
0.31
7.4
5.2
1.42
1.97
ug/l
1.52
40
394
12
152
0.77
0.31
2.8
2.3
—
—
—
0
0
55
599
0.88
0.30
1.9
1.9
1.30
1.32
mmol/l
0.06
40
510
51
555
0.88
0.27
5.7
3.5
0.00
0.00
estimate
-0.00
16
120
29
328
0.86
0.26
7.2
3.8
1.02
1.02
kg/l
0.46
18
217
129
1249
1.14
0.26
5.9
5.2
1.79
1.92
mu/l
0.52
120
1147
9
77
1.18
0.25
4.0
3.8
4.71
4.62
pmol/l
—
9
71
0
11
0.00
0.21
0.0
1.5
—
13.22
—
0
11
0
11
0.00
0.21
0.0
3.3
—
30.52
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
9
113
0.79
0.20
1.6
1.2
—
—
—
0
0
17
146
1.18
0.20
14.4
6.9
—
—
—
0
0
132
1351
0.89
0.20
5.4
5.0
4.65
4.64
mmol/l
0.03
123
1255
25
278
0.88
0.18
2.8
3.1
0.69
0.78
ug/l
0.17
13
169
145
1469
0.91
0.12
47.6
20.0
4.30
4.53
e12/l
5.66
140
1440
126
1281
0.93
0.10
4.8
4.1
1.32
1.27
mmol/l
0.33
117
1174
27
253
1.08
0.09
2.2
1.6
—
—
—
0
0
6
71
0.84
0.08
1.0
1.1
—
—
—
0
0
131
1316
0.98
0.00
6.0
4.9
6.21
5.88
mmol/l
0.82
120
1208
45
452
0.99
0.00
6.3
3.5
17.52
6.99
mg/mmol
0.95
26
277
6
65
0.92
0.00
1.3
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
68.50
—
0
7
0
7
0.00
0.00
0.0
1.4
—
203.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
115.60
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
8.86
—
0
6
6
60
1.00
-0.00
1.3
1.2
1.49
1.54
g/l
—
6
60
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_ACTINOMYCOSIS_WIDE – Actinomycosis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).